Principal Securities, Inc. Bio N Tech Se Transaction History
Principal Securities, Inc.
- $5.32 Trillion
- Q2 2025
A detailed history of Principal Securities, Inc. transactions in Bio N Tech Se stock. As of the latest transaction made, Principal Securities, Inc. holds 63 shares of BNTX stock, worth $6,429. This represents 0.0% of its overall portfolio holdings.
Number of Shares
63
Previous 97
35.05%
Holding current value
$6,429
Previous $11.1 Million
39.31%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding BNTX
# of Institutions
321Shares Held
40.9MCall Options Held
1.38MPut Options Held
1.52M-
Baillie Gifford & CO8.04MShares$820 Million0.67% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.23MShares$432 Million1.88% of portfolio
-
Primecap Management CO Pasadena, CA4MShares$408 Million0.35% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.6MShares$367 Million0.24% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$193 Million0.0% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $24.8B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...